Delisting risk
CELZ · NASDAQ · Biotechnology

Creative Medical Technology

Develops regenerative cell therapies for pain and diabetes alongside physician-use procedure kits.

$1.13
After-hours close−0.03 (−2.42%)
At close$1.16(+1.58%)

Breakdown13F · Form 4

Institutions Insiders

Shares outstanding 2.58M · Float 2.38M · 92.4% free float

Insiders — no current Form 4 position.

Top shareholders13F · 13D/G · Form 4

No 13F, 13D/G or Form 4 holder on record.

Institutions13F

No 13F holders on record.

Beneficial owners13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

InsidersForm 4

No current Form 4 position on record.

2 ten-percent owners hold 22.7K shares by Form 4, outside the officers-and-directors figure above · 5 people have not refiled in the last 18 months (13.5K shares), so they are not in the figure above

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.